삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

산부인과 이정원 교수

진료분야
자궁경부암, 난소암, 자궁내막암
진료일정 06 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
오전
오후
진료일정 07 月
날짜
금
01
토
02
일
03
월
04
화
05
수
06
목
07
금
08
토
09
일
10
월
11
화
12
수
13
목
14
금
15
토
16
일
17
월
18
화
19
수
20
목
21
금
22
토
23
일
24
월
25
화
26
수
27
목
28
금
29
토
30
일
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2010.08 고려대학교 대학원 산부인과학 박사
2005.02 성균관대학교 대학원 의학과 석사
1995.02 경상대학교 의과대학 의학사
1991.02 경상대학교 자연과학대 의예과

경력

경력
2021.04 ~현재 성균관대학교 의과대학 산부인과학교실 주임교수 및 삼성서울병원 산부인과장
2019.04 ~현재 성균관대학교 의과대학 산부인과학교실 교수
2016.12 ~현재 삼성서울병원 암병원 부인암센터장
2005.03 ~현재 삼성서울병원 산부인과 전문의
2003.04 ~현재 삼성서울병원 암병원 부인암센터 교수
2013.03 ~ 2019.03 성균관대학교 의과대학 산부인과학교실 부교수
2009.03 ~ 2013.03 성균관대학교 의과대학 산부인과학교실 조교수
2005.03 ~ 2009.02 삼성서울병원 산부인과 임상조교수
2007.05 ~ 2008.12 미국 MD Anderson 암센터 방문 조교수
2003.04 ~ 2005.02 삼성서울병원 산부인과 부인종양 전임의
2000.05 ~ 2003.04 공중보건의 근무
2000.03 산부인과 전문의 자격 취득
1996.02 ~ 2000.02 삼성서울병원 산부인과 레지던트 과정 수료
1995.03 ~ 1996.02 삼성서울병원 인턴과정 수료

학회활동

학회활동
2017.03 ~ 현재 대한산부인과내시경학회 상임이사
2017.03 ~ 현재 대한부인종양학회 상임이사
2015.01 ~ 2017.09 (재) 건강한여성재단 사무총장
2016.03 ~ 2016.10 대한부인종양학회 사무총장

수상이력

수상이력
2014.04 Tokyo International Forum, Japan Patient-derived Tumor Xenograft Model for Gynecologic Cancer 구연상
2010.10 Interaction with microRNA-200c and BRD7 in endometrial carcinoma 대한산부인과학회 최우수구연상
  • " alt="" />
  • " alt="" />

여성환자들의 미래이자 희망. 난치암 정보를 준비하는 산부인과 이정원 교수

Oh Happy SMC 블로그
논문
  • FRONT ONCOL 2021 10.3389/fonc.2021.670214 Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix Jung1, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • EUR J GYNAECOL ONCOL 2021 10.31083/j.ejgo.2021.01.2209 Port site implantation of clear cell carcinoma after laparoscopic ovarian cystectomy Noh1, JJ; Choi, KH; Kim, HS; Lee, JW
    View PubMed
  • TAIWAN J OBSTET GYNECOL 2021 10.1016/j.tjog.2020.11.020 Vulvar epithelioid sarcoma: A case report with literature review Noh1, JJ; Jeon, JE; Jung, H; Kim, HS; Lee, YY; Choi, CH; Lee, JW
    View PubMed
  • CELL DEATH DIS 2020 10.1038/s41419-020-03242-x Chloroquine reverses chemoresistance via upregulation of p21(WAF1/CIP1) and autophagy inhibition in ovarian cancer Hwang1, JR; Kim, WY; Cho, YJ; Ryu, JY; Choi, JJ; Jeong, SY; Kim, MS; Kim, JH; Paik, ES; Lee, YY; Han, HD; Lee, JW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113471 Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type Kang1, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH
    View PubMed
  • CANCERS 2020 10.3390/cancers12113188 Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer A Korean Multi-Center Retrospective Study (KGOG1041) Choi1, MC; Kim, YM; Lee, JW; Lee, YJ; Suh, DH; Lee, SJ; Lee, TS; Lee, M; Park, DC; Kim, MK; Lee, JM; Shim, SH; Jeon, S; Min, KJ; Kim, MK; Kim, BW; Park, JY; Kim, BG; Kim, DY; Kim, MH; Kim, HS; Lee, JY
    View PubMed
  • INT J NANOMEDICINE 2020 10.2147/IJN.S272319 Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma Wi1, TI; Won, JE; Lee, CM; Lee, JW; Kang, TH; Shin, BC; Han, HD; Park, YM
    View PubMed
  • PHARMACEUTICS 2020 10.3390/pharmaceutics12100987 Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer Noh1, JJ; Kim, MS; Cho, YJ; Jeong, SY; Lee, YY; Ryu, JY; Choi, JJ; Bae, I; Wu, Z; Kim, BG; Hwang, JR; Lee, JW
    View PubMed
  • CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557 Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer Choi1, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.583515 Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor Kang1, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ
    View PubMed
  • GUT LIVER 2020 10.5009/gnl20187 Anxiety and Depression in Patients with Inflammatory Bowel Diseases The First Step toward Proper Management Lee1, JW
    View PubMed
  • EUR J CANCER 2020 10.1016/j.ejca.2020.03.030 Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R) Choi1, MC; Chung, YS; Lee, JW; Kwon, BS; Park, BK; Kim, SI; Shim, SH; Lee, KB; Seong, SJ; Lee, SJ; Lee, SH; Yoo, HJ; Song, T; Kim, MK; Baek, MH; Kang, S; Kim, YM
    View PubMed
  • THER ADV MED ONCOL 2020 10.1177/1758835920926796 First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients Kim1, ST; Hong, JY; Park, SH; Park, JO; Park, YW; Park, N; Lee, H; Hong, SH; Lee, SJ; Song, SW; Kim, K; Park, YS; Lim, HY; Kang, WK; Nam, H; Lee, JW; Park, K; Kim, KM; Lee, J
    View PubMed
  • HELICOBACTER 2020 10.1111/hel.12685 Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea Yoon1, K; Kim, N; Lee, JW; Yoon, H; Shin, CM; Park, YS; Lee, DH
    View PubMed
  • INFLAMM BOWEL DIS 2020 10.1093/ibd/izz317 Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-kappa B Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis Lee1, JW; Lee, SM; Chun, J; Im, JP; Seo, SK; Ha, N; Choi, YI; Kim, JS
    View PubMed
  • J CONTROL RELEASE 2020 10.1016/j.jconrel.2020.02.013 KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer Lee1, J; Cho, YJ; Lee, JW; Ahn, HJ
    View PubMed
  • Front Oncol 2020 10.3389/fonc.2020.00451 Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer Paik1, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.328 Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status Jeong1, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041137 Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis Kim1, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • J GYNECOL ONCOL 2020 10.3802/jgo.2020.31.e15 Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study Park1, SJ; Kim, J; Kim, HS; Lee, JW; Chang, H; Lee, KH; Kim, DY; Kim, S; Chang, SJ; Han, SS; Park, SY; Shim, SH
    View PubMed
  • J BIOMED NANOTECHNOL 2020 10.1166/jbn.2020.2883 Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d,l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy Wi1, TI; Byeon, Y; Won, JE; Lee, JM; Kang, TH; Lee, JW; Lee, YJ; Sood, AK; Han, HD; Park, YM
    View PubMed
  • J MINIM INVAS GYN 2020 10.1016/j.jmig.2019.04.005 In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model Kim1, J; Eom, HJ; Shin, H; Jeong, SY; Kim, MS; Yoon, HS; In, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • BIOCHEM PHARMACOL 2020 10.1016/j.bcp.2019.113735 Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects Seraj1, S; Cho, YJ; Lee, JW; Ahn, HJ
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004 CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer Kim1, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9010147 Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer Choi1, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG
    View PubMed
  • J Minim Invasive Gynecol. 2019 Apr 6. pii: S1553-4650(19)30154-2. doi: 10.1016/j.jmig.2019.04.005. [Epub ahead of print] In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model Kim J1, Eom HJ, Shin H, Jeong SY, Kim MS, Yoon HS, In CH, Kim BG, Bae DS, Lee JW.
    View PubMed
  • J Gynecol Oncol. 2019 Jul;30(4):e65. doi: 10.3802/jgo.2019.30.e65. Epub 2019 Mar 11. Prediction of Survival Outcomes in Patients with Epithelial Ovarian Cancer using Machine Learning Methods E Sun Paik1, Jeong-Won Lee, Jeong-Yeol Park, Ju-Hyun Kim, Mijung Kim, Tae-Joong Kim, Chel Hun Choi, Byoung-Gie Kim, Duk-Soo Bae, Sung Wook Seo
    View PubMed
  • Genome Biol. 2019 Nov 26;20(1):253. doi: 10.1186/s13059-019-1848-3. Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers Sa JK1, Hwang JR, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, Her NG, Shin YJ, Cho HJ, Kim JY, Seo YJ, Koo H, Oh JW1, Lee T, Kim HS, Song SY, Bae JS, Park WY, Han HD, Ahn HJ, Sood AK, Rabadan R, Lee JK, Nam DH, Lee JW.
    View PubMed
  • Obstet Gynecol Sci. 2019 Mar;62(2):103-111. doi: 10.5468/ogs.2019.62.2.103. Epub 2019 Feb 12 Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases E Sun Paik1, Jae Hong Kang, Jihye Kim, Yeon-Joo Lee, Chel Hun Choi, Tae-Joong Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee
    View PubMed
  • J OVARIAN RES 2019 10.1186/s13048-019-0602-5 Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer Jeong1, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-51959-3 Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW
    View PubMed
  • EUR J CANCER CARE 2019 10.1111/ecc.13089 Influence of time lapse after cancer diagnosis on the association between unmet needs and quality of life in family caregivers of Korean cancer patients Shin1, J; Ko, H; Lee, JW; Kim, K; Song, YM
    View PubMed
  • J VIROL METHODS 2019 10.1016/j.jviromet.2019.04.012 Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay Cho1, HW; Ouh, YT; Hong, JH; Min, KJ; So, KA; Kim, TJ; Paik, ES; Lee, JW; Moon, JH; Lee, JK
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e65 Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods Paik1, ES; Lee, JW; Park, JY; Kim, JH; Kim, M; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Seo, SW
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5514-7 Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708) Chung1, YS; Park, SY; Lee, JY; Park, JY; Lee, JW; Kim, HS; Suh, DS; Kim, YH; Lee, JM; Kim, M; Choi, MC; Shim, SH; Lee, KH; Song, T; Hong, JH; Lee, WM; Lee, B; Lee, IH
    View PubMed
  • ARCH GYNECOL OBSTET 2019 10.1007/s00404-018-4996-x Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy Cheong1, IY; Yoo, JS; Chung, SH; Park, SY; Song, HJ; Lee, JW; Hwang, JH
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e31 Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline Min1, KJ; Kwon, SH; Kim, K; Kim, S; Kim, HJ; Seong, SJ; Song, YJ; Lee, KH; Lee, SW; Lee, JW; Chang, SJ; Ju, W; Kim, YT; Lee, JK
    View PubMed
  • GYNECOL ONCOL 2019 10.1016/j.ygyno.2018.10.031 Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) Lee1, JY; Park, JY; Park, SY; Lee, JW; Kim, JW; Kim, YB; Jeong, DH; Lee, KB; Kim, TH; Lee, IH; Choi, MC; Kim, KH; Kim, YM; Lee, YJ; Kang, S; Pujade-Lauraine, E; Shin, SJ; Hong, DG; Shim, SH; Kim, YH; Song, T; Bae, J; Lee, JM; Lee, SH; Lee, EJ; Park, SI; Lee, SJ; Lee, C; Lee, TS; Chang, SJ; Kim, MK
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e11 Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff? Kim1, J; Chang, Y; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J Clin Oncol. 2018 Sep 20;36(27):2778-2786. doi: 10.1200/JCO.2018.77.7912. Epub 2018 Aug 3. Disparities in cervical cancer screening among women with disabilities: a national database study in South Korea Dong Wook Shin1, Jeong-Won Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Jong eon Park, Jong Hyock Park
    View PubMed
  • INT J GYNECOL OBSTET 2018 10.1002/ijgo.12653 Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer Lee1, YY; Lee, JW; Lu, L; Xu, W; Kollara, A; Brown, T; Heo, EJ; May, T
    View PubMed
  • DRUG DELIV 2018 10.1080/10717544.2018.1480672 Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer Kim1, GH; Won, JE; Byeon, Y; Kim, MG; Wi, TI; Lee, JM; Park, YY; Lee, JW; Kang, TH; Jung, ID; Shin, BC; Ahn, HJ; Lee, YJ; Sood, AK; Han, HD; Park, YM
    View PubMed
  • CANCER RES 2018 10.1158/0008-5472.CAN-17-3871 CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer Byeon1, Y; Lee, JW; Choi, WS; Won, JE; Kim, GH; Kim, MG; Wi, TI; Lee, JM; Kang, TH; Jung, ID; Cho, YJ; Ahn, HJ; Shin, BC; Lee, YJ; Sood, AK; Han, HD; Park, YM
    View PubMed
  • Front Oncol 2018 10.3389/fonc.2018.00465 Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma Kim1, J; Chung, JY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • NAT GENET 2018 10.1038/s41588-018-0209-6 Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy Lee1, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH
    View PubMed
  • EUR J OBSTET GYN R B 2018 10.1016/j.ejogrb.2018.06.034 The role of appendectomy in patients with mucinous borderline ovarian tumors Song1, T; Kim, MK; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001316 Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis Choi1, HJ; Paik, ES; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e56 Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement Suh1, DH; Chang, SJ; Song, T; Lee, S; Kang, WD; Lee, SJ; Roh, JW; Joo, WD; Yoon, JH; Jeong, DH; Kim, HS; Lee, SJ; Ji, YI; Kim, HJ; Lee, JW; Kim, JW; Bae, DS
    View PubMed
  • EUR J NUCL MED MOL I 2018 10.1007/s00259-018-3975-6 Preoperative [F-18]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study Lee1, JW; Park, JY; Lee, HJ; Lee, JJ; Moon, SH; Kang, SY; Cheon, GJ; Chung, HH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.104 Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer Paik1, ES; Choi, HJ; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18 Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis Paik1, ES; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e13 Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer Paik1, ES; Kim, JH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • GYNECOL OBSTET INVES 2018 10.1159/000475817 Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis? Song1, T; Lee, DH; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0189847 Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation Shim1, SH; Lim, MC; Kim, HJ; Lee, M; Nam, EJ; Lee, JY; Lee, YY; Lee, KB; Park, JY; Kim, YH; Ki, KD; Song, YJ; Chung, HH; Kim, S; Lee, JW; Kim, JW; Bae, DS; Lee, JM
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.322 Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies Heo1, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-017-4765-4 Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids Kim1, YS; Kim, TJ; Lim, HK; Rhim, H; Jung, SH; Ahn, JH; Lee, JW; Kim, BG
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.034 Proton. Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer Song1, T; Jeon, HK; Hong, JE; Choi, JJ; Kim, TJ; Choi, CH; Bae, DS; Kim, BG; Lee, JW
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-06510-7 The anti-cancer effects of itraconazole in epithelial ovarian cancer Choi1, CH; Ryu, JY; Cho, YJ; Jeon, HK; Choi, JJ; Ylaya, K; Lee, YY; Kim, TJ; Chung, JY; Hewitt, SM; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.282 Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer Paik1, ES; Sohn, I; Baek, SY; Shim, M; Choi, HJ; Kim, TJ; Choi, CH; Lee, JW; Kim, BG; Lee, YY; Bae, DS
    View PubMed
  • JOURNAL OF GYNECOLOGIC ONCOLOGY, MAY 2017, 28(3), DOI: 10.3802/jgo.2017.28.e28 Prognostic significance of preoperative F-18-FDG PET/CT in uterine leiomyosarcoma Park JY1, Lee JW, Lee HJ, Lee JJ, Moon SH, Kang SY, Cheon GJ, Chung HH
    View PubMed
  • Int J Gynecol Cancer. 2017 Mar;27(3):507-513. doi: 10.1097/IGC.0000000000000909. Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients Yang K11, Park W, Huh SJ, Park BK, Kim CK, Kim BG, Bae DS, Lee JW.
    View PubMed
  • J Gynecol Oncol. 2017 Jan;28(1):e12. doi: 10.3802/jgo.2017.28.e12. Epub 2016 Oct 27. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement Lee SW11, Lee TS2, Hong DG3, No JH4, Park DC5, Bae JM6, Seong SJ7, Shin SJ8, Ju W9, Lee KH10, Lee YK11, Cho H12, Lee C13, Paek J14, Kim HJ15, Lee JW16, Kim JW17, Bae DS16.
    View PubMed
  • Sci Rep. 2016 Dec 5;6:38502. doi: 10.1038/srep38502. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma Kim HJ11, Yoon A2, Ryu JY2, Cho YJ2, Choi JJ2, Song SY3, Bang H3, Lee JS4, Cho WC5, Choi CH2, Lee JW2,6,7, Kim BG2, Bae DS2.
    View PubMed
  • Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9. Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery Paik ES11, Lee YY1, Shim M1, Choi HJ1, Kim TJ1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer Paik ES1, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Sci Rep. 2016 Dec 2;6:38348. doi: 10.1038/srep38348. In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy Han HD11, Byeon Y1, Jang JH2, Jeon HN1, Kim GH1, Kim MG1, Pack CG3, Kang TH1, Jung ID1, Lim YT4, Lee YJ5, Lee JW6, Shin BC7, Ahn HJ8, Sood AK9,10,11, Park YM1.
    View PubMed
  • Anticancer Res. 2016 Dec;36(12):6381-6388. Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells Lee YY11, Jeon HK2, Lee J3, Hong JE2, Do IG4, Choi CH2, Kim TJ2, Kim BG2, Bae DS2, Kim YC3, Lee JW5.
    View PubMed
  • J Korean Med Sci. 2016 Dec;31(12):1969-1975. doi: 10.3346/jkms.2016.31.12.1969. Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K) Nam SH11, Choi HJ2, Kang WD3, Kim SM3, Lim MC4, Park SY4, Kim JS5, Kim BG2, Bae DS2, Lee JW2, Kim TJ2, Song T6.
    View PubMed
  • Sci Rep. 2016 Dec 23;6:39334. doi: 10.1038/srep39334. The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis Hwang JR11, Cho YJ2,3, Lee Y1, Park Y1, Han HD4, Ahn HJ5, Lee JH6, Lee JW2,3,7.
    View PubMed
  • Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/j.ygyno.2016.08.321. Epub 2016 Aug 25. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis Paik ES11, Shim M1, Choi HJ1, Lee YY2, Kim TJ1, Lee JW1, Kim BG1, Bae DS1, Choi CH3.
    View PubMed
  • Eur Radiol. 2016 Nov;26(11):4148-4154. Epub 2016 Feb 16. Prognostic value of total lesion glycolysis on preoperative F-18-FDG PET/CT in patients with uterine carcinosarcoma Lee JW11,2, Heo EJ1, Moon SH3, Lee H4, Cheon GJ4, Lee M5, Kim HS5, Chung HH6.
    View PubMed
  • Int J Nanomedicine. 2016 Nov 2;11:5729-5742. eCollection 2016. Toll-like receptor 3-induced immune response by poly(D, L-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy Han HD11, Byeon Y1, Kang TH1, Jung ID1, Lee JW2, Shin BC3, Lee YJ4, Sood AK5, Park YM1.
    View PubMed
  • INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9(10):19654-19663 Pulmonary benign metastasizing leiomyoma: clinical and therapeutic analyses of 11 patients treated at a single institution Kim HS1, Yoon G, Lee JS, Han J, Song SY, Kim BG, Bae DS, Lee JW
    View PubMed
  • J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer Paik ES11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Int J Gynecol Cancer. 2016 Sep;26(7):1252-7. doi: 10.1097/IGC.0000000000000762. Long-term Outcomes of MRI Stage IIB Cervical Cancer Yoon A11, Park JJ, Park BK, Lee YY, Paik ES, Choi CH, Kim TJ, Kim CK, Lee JW, Bae DS, Kim BG.
    View PubMed
  • BMC Cancer. 2016 Jul 11;16:448. doi: 10.1186/s12885-016-2459-y. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer Choi CH11,2, Chung JY1, Chung EJ3, Sears JD1, Lee JW2, Bae DS4, Hewitt SM5.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e27. doi: 10.3802/jgo.2016.27.e27. Time-lapse imaging of sentinel lymph node using indocyanine green with near-infrared fluorescence imaging in early endometrial cancer Choi HJ11, Kim TJ2, Lee YY1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer Paik ES11, Lee YY1, Kim TJ1, Choi CH1, Lee JW2, Kim BG1, Bae DS1.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e30. doi: 10.3802/jgo.2016.27.e30. Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline Min KJ11, Kwon SH2, Kim S3, Kim HJ4, Seong SJ5, Song YJ6, Shin JW7, Lee KH8, Lim MC9, Chung HH10, Ju W11, Hong JH1, Lee JW12, Kim JW10, Bae DS12, Lee JK13.
    View PubMed
  • Mol Cancer Ther. 2016 Apr;15(4):618-27. doi: 10.1158/1535-7163.MCT-15-0733-T. Epub 2016 Feb 9. Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma Han HD11, Cho YJ2, Cho SK3, Byeon Y1, Jeon HN1, Kim HS4, Kim BG5, Bae DS5, Lopez-Berestein G6, Sood AK7, Shin BC8, Park YM9, Lee JW10.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:208-12. doi: 10.1016/j.ejogrb.2015.07.018. Epub 2015 Aug 20. Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome Song T11, Kim MK2, Lee YY3, Choi CH3, Kim TJ3, Lee JW3, Bae DS3, Kim BG4.
    View PubMed
  • JSLS. 2016 Apr-Jun;20(2). pii: e2016.00001. doi: 10.4293/JSLS.2016.00001 Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy Kim TH11, Kim CJ1, Kim TJ2, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • J Gynecol Oncol. 2016 Mar;27(2):e20. doi: 10.3802/jgo.2016.27.e20. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer Park JY11, Heo EJ1, Lee JW2, Lee YY1, Kim TJ1, Kim BG1, Bae DS1.
    View PubMed
  • Radiology. 2016 Mar;278(3):925-35. doi: 10.1148/radiol.2015150608. Epub 2015 Aug 27. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Lee JW1, Choi CH1, Kim BG1, Bae DS1, Rhim H1, Lim HK1.
    View PubMed
  • Arch Gynecol Obstet. 2016 Jan;293(1):157-62. doi: 10.1007/s00404-015-3801-3. Epub 2015 Jul 9. Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Kim BG3, Bae DS3, Hwang JH4, Lee JW5.
    View PubMed
  • Carcinogenesis. 2015 Dec;36(12):1561-71. doi: 10.1093/carcin/bgv140. Epub 2015 Oct 6. Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer Bae T1, Weon KY1, Lee JW2, Eum KH3, Kim S4, Choi JW5.
    View PubMed
  • Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283. HER2 as a novel therapeutic target for cervical cancer Oh DY11,2,3, Kim S1, Choi YL1,2,3, Cho YJ4, Oh E2,3, Choi JJ4, Jung K3, Song JY2, Ahn SE2, Kim BG4, Bae DS4, Park WY3,5, Lee JW2,3,4, Song S1,2.
    View PubMed
  • Oncotarget. 2015 Oct 27;6(33):35040-50. doi: 10.18632/oncotarget.5319. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma Lee YY11, Jeon HK1, Hong JE1, Cho YJ1, Ryu JY1, Choi JJ1, Lee SH2, Yoon G3, Kim WY4, Do IG5, Kim MK6, Kim TJ1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • J Gynecol Oncol. 2015 Oct;26(4):270-6. doi: 10.3802/jgo.2015.26.4.270. Epub 2015 Jul 17. Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors Paik ES11, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Oncotarget. 2015 Oct 13;6(31):31030-8. doi: 10.18632/oncotarget.5208. Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer Kim YR11, Park MS2, Eum KH3, Kim J3, Lee JW4, Bae T5, Lee DH6, Choi JW3,7.
    View PubMed
  • Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer Kim HS11, Yoon G2, Ryu JY3, Cho YJ3, Choi JJ3, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3,5.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:48-51. doi: 10.1016/j.ejogrb.2015.04.014. Epub 2015 May 1. A prospective comparative study of cosmetic satisfaction for three different surgical approaches Song T11, Park JY2, Kim TJ3, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30. doi: 10.1016/j.ejogrb.2015.04.005. Epub 2015 Apr 16. The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Cancer. 2015 Jul 1;137(1):221-9. doi: 10.1002/ijc.29362. Epub 2014 Dec 8. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer Lee JW11, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407. Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer Vaginal Versus Laparoscopic Approaches Yoon A11, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2015 Jul;26(3):222-6. doi: 10.3802/jgo.2015.26.3.222. Robotic high para-aortic nymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients Kim TJ11, Yoon G2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG3.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5318-26. eCollection 2015. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis Kim HS11, Yoon G2, Lee YY3, Kim TJ3, Choi CH3, Lee JW3, Kim BG3, Bae DS3, Song SY4.
    View PubMed
  • Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404. Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy Yoon A11, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5688-94. eCollection 2015. Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3.
    View PubMed
  • Taiwan J Obstet Gynecol. 2015 Apr;54(2):150-4. doi: 10.1016/j.tjog.2014.05.005. Is laparoendoscopic single-site surgery (LESS) retroperitoneal hysterectomy feasible: Surgical outcomes of the initial 27 cases Kim TH11, Kim TJ2, Yoo HN1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68. Asian Society of Gynecologic Oncology International Workshop 2014 Park JY11, Ngan HY2, Park W3, Cao Z4, Wu X5, Ju W6, Chung HH7, Chang SJ8, Park SY9, Ryu SY10, Kim JH11, Cho CH12, Lee KH13, Lee JW14, Kumarasamy S15, Kim JW7, Wilailak S16, Kim BG14, Kim DY1, Konishi I17, Lee JK18, Wang KL19, Nam JH20.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42. doi: 10.1016/j.ejogrb.2014.10.001. Epub 2014 Oct 14. Borderline ovarian tumor in women aged >= 65 years: impact on recurrence and survival Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):62-7. doi: 10.3802/jgo.2015.26.1.62. Single-site robotic surgery in gynecologic cancer: a pilot study Yoo HN11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Radiology. 2014 Nov;273(2):462-71. doi: 10.1148/radiol.14132719. Epub 2014 Jul 1. Uterine Fibroids: Semiquantitative Perfusion MR Imaging Parameters Associated with the Intraprocedural and Immediate Postprocedural Treatment Efficiencies of MR Imaging-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.
    View PubMed
  • Gynecol Oncol. 2014 Oct;135(1):108-17. doi: 10.1016/j.ygyno.2014.06.031. Epub 2014 Jul 9. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma Park YA11, Choi CH1, Do IG2, Song SY2, Lee JK3, Cho YJ1, Choi JJ1, Jeon HK1, Ryu JY1, Lee YY1, Kim TJ1, Bae DS1, Lee JW4, Kim BG5.
    View PubMed
  • Int J Gynecol Cancer. 2014 Oct;24(8):1466-73. doi: 10.1097/IGC.0000000000000232. Robotic Versus Laparoscopic Radical Hysterectomy in Cervical Cancer Patients A Matched-Case Comparative Study Kim TH11, Choi CH, Choi JK, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings Kim HJ11, Choi CH2, Lee YY2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197. Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix Kim HJ11, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1206-14. doi: 10.1097/IGC.0000000000000216. Risk Factors for Progression to Invasive Carcinoma in Patients With Borderline Ovarian Tumors Song T11, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Am J Obstet Gynecol. 2014 Aug;211(2):168.e1-7. doi: 10.1016/j.ajog.2014.02.032. Epub 2014 Mar 4. Postoperative outcomes of MR-invisible stage IB1 cervical cancer Park JY11, Lee JW1, Park BK2, Lee YY1, Choi CH1, Kim TJ1, Bae DS1, Kim BG1, Park JJ3, Park SY3, Kim CK3.
    View PubMed
  • J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):580-5. doi: 10.1016/j.jmig.2013.12.096. Epub 2013 Dec 31. Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique Choi CH11, Kim TH1, Kim SH1, Choi JK1, Park JY1, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Kim BG1, Bae DS2.
    View PubMed
  • J Cancer Res Clin Oncol. 2014 Jul;140(7):1179-88. doi: 10.1007/s00432-014-1658-7. Epub 2014 Mar 27. Meta-analysis of the effects of beta blocker on survival time in cancer patients Choi CH11, Song T, Kim TH, Choi JK, Park JY, Yoon A, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Support Care Cancer. 2014 May;22(5):1181-7. doi: 10.1007/s00520-013-2070-6. Epub 2013 Dec 12. Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin Choi CH11, Kim MK, Park JY, Yoon A, Kim HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):254-9. doi: 10.1089/lap.2013.0507. Epub 2014 Feb 25. Comparison of Laparoendoscopic Single-Site Hysterectomies: Laparoscopic Hysterectomy with Some Vaginal Component Versus Laparoscopically Assisted Vaginal Hysterectomy Kim TJ11, Song T, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:58-61. doi: 10.1016/j.ejogrb.2014.01.004. Epub 2014 Jan 17. Laparoendoscopic single-site (LESS) myomectomy: characteristics of the appropriate myoma Yoon A11, Kim TJ1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6. Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma Park YA11, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2014 Jan;24(1):107-12. doi: 10.1097/IGC.0000000000000015. Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors Yoon A11, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2014 Jan;132(1):70-5. doi: 10.1016/j.ygyno.2013.10.029. Epub 2013 Oct 31. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases Yoon A11, Park JY2, Park JY1, Lee YY1, Kim TJ1, Choi CH1, Bae DS1, Kim BG1, Lee JW3, Nam JH4.
    View PubMed
  • Gynecol Oncol. 2013 Dec;131(3):650-4. doi: 10.1016/j.ygyno.2013.10.003. Epub 2013 Oct 18. Genetic profiling to predict recurrence of early cervical cancer Lee YY11, Kim TJ, Kim JY, Choi CH, Do IG, Song SY, Sohn I, Jung SH, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Anticancer Res. 2013 Aug;33(8):3177-84. The Effect of Surgical Wound on Ovarian Carcinoma Growth in an Animal Model Lee JW11, Park YA, Cho YJ, Kang KH, Choi JJ, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    View PubMed
  • Anticancer Res. 2013 Apr;33(4):1555-61. Clinical Significance of Galectin-7 in Epithelial Ovarian Cancer Kim HJ11, Jeon HK, Lee JK, Sung CO, Do IG, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.
    View PubMed
  • J Gynecol Oncol. 2013 Apr;24(2):186-203. doi: 10.3802/jgo.2013.24.2.186. Epub 2013 Apr 5. Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition Lee JK11, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, Kim YM, Kim JW, Kim JH, Kim TJ, Kim HJ, Kim HS, Ryu HS, Song JY, Ahn HS, Yoo CW, Yoon HK, Lee KH, Lee A, Lee Y, Lee IH, Lee JW, Lee TS, Lim MC, Chang SJ, Chung HH, Ju W, Joo HJ, Hur SY, Hong SR, Nam JH.
    View PubMed
  • J Minim Invasive Gynecol. 2013 Mar-Apr;20(2):166-71. doi: 10.1016/j.jmig.2012.10.008. Epub 2013 Jan 5. Management and Outcome of Rectal Injury During Gynecologic Laparoscopic Surgery Jo EJ11, Lee YY, Kim TJ, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Mol Pharm. 2013 Feb 4;10(2):763-73. doi: 10.1021/mp300344p. Epub 2013 Jan 14. Efficient siRNA Delivery into Tumor Cells by p19-YSA Fusion Protein Choi KM11, Park GL, Hwang KY, Lee JW, Ahn HJ.
    View PubMed
  • J Gynecol Oncol. 2013 Jan;24(1):96-7. doi: 10.3802/jgo.2013.24.1.96. Epub 2013 Jan 8. Pharmacokinetics and cytotoxic effect of selenium compounds in rodent cancer xenograft model for therapy experiment Reply 1,Hwang JY1.
    View PubMed
  • Hum Pathol. 2013 Jan;44(1):62-8. doi: 10.1016/j.humpath.2012.04.010. Epub 2012 Aug 30. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer Kim HJ11, Do IG, Jeon HK, Cho YJ, Park YA, Choi JJ, Sung CO, Lee YY, Choi CH, Kim TJ, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Int J Clin Oncol. 2012 Dec;17(6):590-7. doi: 10.1007/s10147-011-0329-9. Epub 2011 Oct 13. Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer Song T11, Lee JW, Choi CH, Kim TJ, Bae DS, Sung CO, Song SY, Kim BG.
    View PubMed
  • Anticancer Res. 2012 Dec;32(12):5285-9. The Effect of High-intensity Focused Ultrasound in Combination with Cisplatin Using a Xenograft Model of Cervical Cancer Lee YY11, Cho YJ, Choi JJ, Choi CH, Kim TJ, Kim BG, Bae DS, Kim YS, Lee JW.
    View PubMed
  • Ann Surg Oncol. 2012 Nov;19(12):3839-48. doi: 10.1245/s10434-012-2406-3. Epub 2012 May 30. Comparison of Laparoscopic-Assisted Radical Vaginal Hysterectomy and Laparoscopic Radical Hysterectomy in the Treatment of Cervical Cancer Choi CH11, Lee JW, Lee YY, Kim HJ, Song T, Kim MK, Kim TJ, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2012 Oct;23(4):226-34. doi: 10.3802/jgo.2012.23.4.226. Epub 2012 Sep 19. Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer Park JY11, Kim DY, Kim JH, Kim YM, Kim YT, Kim YS, Kim HJ, Lee JW, Kim BG, Bae DS, Huh SJ, Nam JH.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):180-4. doi: 10.1016/j.ejogrb.2012.05.029. Epub 2012 Sep 7. Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia Lee YY11, Song SY, Do IG, Kim TJ, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Eur J Cancer. 2012 Aug;48(12):1914-21. doi: 10.1016/j.ejca.2012.02.005. Epub 2012 Mar 2. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion Kim HJ11, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2012 Jul;23(3):190-6. doi: 10.3802/jgo.2012.23.3.190. Epub 2012 Jul 2. The effects of selenium on tumor growth in epithelial ovarian carcinoma Park JS11, Ryu JY, Jeon HK, Cho YJ, Park YA, Choi JJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Mol Cell Biol. 2012 Jun;4(3):164-73. doi: 10.1093/jmcb/mjs018. Epub 2012 Apr 24. Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer Choi JW11, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S.
    View PubMed
  • Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28. Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer Song T11, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Gynecol Oncol. 2012 Jan;124(1):125-33. doi: 10.1016/j.ygyno.2011.09.026. Epub 2011 Oct 19. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma Park YA11, Lee JW, Choi JJ, Jeon HK, Cho Y, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2011 Dec;22(4):292-4. doi: 10.3802/jgo.2011.22.4.292. Epub 2011 Dec 5. Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma Yoon G11, Kim YS, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Int J Clin Oncol. 2011 Oct;16(5):601-4. doi: 10.1007/s10147-010-0174-2. Epub 2011 Jan 6. Myxoid malignant fibrous histiocytoma of the ovary: a case report Choi SY11, Kim TH, Park HS, Sung CO, Lee JW, Song SY, Kim BG, Bae DS.
    View PubMed
  • Int J Clin Oncol. 2011 Aug;16(4):352-8. doi: 10.1007/s10147-011-0190-x. Epub 2011 Feb 16. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma Kim MK11, Sung CO, Do IG, Jeon HK, Song TJ, Park HS, Lee YY, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Gynecol Oncol. 2011 Jul;122(1):79-82. doi: 10.1016/j.ygyno.2011.03.017. Epub 2011 Apr 13. Prognostic significance of DNA ploidy in stage I endometrial cancer Song T11, Lee JW, Kim HJ, Kim MK, Choi CH, Kim TJ, Bae DS, Kim BG.
    View PubMed
  • Neoplasia. 2011 Apr;13(4):309-19. Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles Shahzad MM11, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, Sabnis N, Deavers MT, Lee JS, Ellis LM, Lopez-Berestein G, McConathy WJ, Prokai L, Lacko AG, Sood AK.
    View PubMed
  • Eur J Cancer. 2011 Apr;47(6):918-25. doi: 10.1016/j.ejca.2010.11.007. Epub 2010 Dec 4. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma Kim CJ11, Lee JW, Choi JJ, Choi HY, Park YA, Jeon HK, Sung CO, Song SY, Lee YY, Choi CH, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Clin Cancer Res. 2011 Apr 1;17(7):1713-21. doi: 10.1158/1078-0432.CCR-10-2081. Epub 2011 Feb 7. Functional Roles of Src and Fgr in Ovarian Carcinoma Kim HS11, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MM, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, Sood AK.
    View PubMed
  • Gynecol Oncol. 2011 Jan;120(1):56-62. doi: 10.1016/j.ygyno.2010.09.022. Epub 2010 Oct 28. The expression of the miRNA-200 family in endometrial endometrioid carcinoma Lee JW11, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.
    View PubMed
  • J Biol Chem. 2010 Nov 12;285(46):35462-70. doi: 10.1074/jbc.M110.109579. Epub 2010 Sep 8. Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis Shahzad MM11, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, Sood AK.
    View PubMed
  • Gynecol Oncol. 2010 Oct;119(1):87-91. doi: 10.1016/j.ygyno.2010.05.030. Epub 2010 Jun 26. Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer Lee YY11, Lee JW, Park HS, Song TJ, Kim MK, Choi CH, Kim TJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Cancer Biol Ther. 2010 Aug 15;10(4):329-35. Epub 2010 Aug 7. Low dynamin 2 expression is associated with tumor invasion and metastasis in invasive squamous cell carcinoma of cervix Lee YY11, Do IG, Park YA, Choi JJ, Song SY, Kim CJ, Kim MK, Song TJ, Park HS, Choi CH, Kim TJ, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Clin Cancer Res. 2010 Aug 1;16(15):3910-22. doi: 10.1158/1078-0432.CCR-10-0005. Epub 2010 Jun 10. Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles Han HD11, Mangala LS, Lee JW, Shahzad MM, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, Lee SJ, Roh JW, Nick AM, Lopez-Berestein G, Sood AK.
    View PubMed
  • Cancer Cell. 2010 Aug 9;18(2):185-97. doi: 10.1016/j.ccr.2010.06.016. Regulation of Tumor Angiogenesis by EZH2 Lu C11, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK.
    View PubMed
  • Clin Cancer Res. 2010 May 1;16(9):2562-70. doi: 10.1158/1078-0432.CCR-10-0017. Epub 2010 Apr 13. EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma Lee JW11, Stone RL, Lee SJ, Nam EJ, Roh JW, Nick AM, Han HD, Shahzad MM, Kim HS, Mangala LS, Jennings NB, Mao S, Gooya J, Jackson D, Coleman RL, Sood AK.
    View PubMed
  • J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205. doi: 10.1093/jnci/djp231. Epub 2009 Jul 29. EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma Lee JW11, Han HD, Shahzad MM, Kim SW, Mangala LS, Nick AM, Lu C, Langley RR, Schmandt R, Kim HS, Mao S, Gooya J, Fazenbaker C, Jackson D, Tice DA, Landen CN, Coleman RL, Sood AK.
    View PubMed
  • Clin Cancer Res. 2009 Jun 1;15(11):3770-80. doi: 10.1158/1078-0432.CCR-08-2306. Epub 2009 May 26. Therapeutic Targeting of ATP7B in Ovarian Carcinoma Mangala LS11, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, Wolf JK, Coleman RL, Siddik ZH, Lopez-Berestein G, Lutsenko S, Sood AK.
    View PubMed
  • Clin Cancer Res. 2009 Apr 15;15(8):2695-702. doi: 10.1158/1078-0432.CCR-08-2966. Epub 2009 Apr 7. Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma Lee JW11, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK.
    View PubMed
  • Clin Cancer Res. 2008 May 1;14(9):2535-42. doi: 10.1158/1078-0432.CCR-07-1231. Altered MicroRNA expression in cervical carcinomas Lee JW11, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2008 Mar-Apr;18(2):300-5. Epub 2007 Jun 22. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia Kim WY11, Lee JW, Choi JJ, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS.
    View PubMed
  • Mol Carcinog. 2007 Nov;46(11):941-7. Increased toll-like receptor 9 expression in cervical neoplasia Lee JW11, Choi JJ, Seo ES, Kim MJ, Kim WY, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):817-22. Epub 2007 Mar 26. Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results Choi CH11, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, Huh SJ, Lee JH, Bae DS.
    View PubMed
  • J Cancer Res Clin Oncol. 2006 Apr;132(4):241-7. Epub 2005 Dec 21. Decreased galectin-3 expression during the progression of cervical neoplasia Lee JW11, Song SY, Choi JJ, Choi CH, Kim TJ, Kim J, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Hum Pathol. 2005 Nov;36(11):1197-203. Epub 2005 Oct 7. eIF-4E expression is associated with histopathologic grades in cervical neoplasia Lee JW11, Choi JJ, Lee KM, Choi CH, Kim TJ, Lee JH, Kim BG, Ahn G, Song SY, Bae DS.
    View PubMed
  • Clin Oncol (R Coll Radiol). 2005 Sep;17(6):412-7. Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix Lee JW11, Kim BG, Lee SJ, Lee SH, Park CS, Lee JH, Huh SJ, Bae DS.
    View PubMed
  • J Korean Med Sci. 2005 Jun;20(3):468-72. Selected adnexal cystic masses in postmenopausal women can be safely managed by lapcroscopy Lee JW11, Kim CJ, Lee JE, Lee SJ, Kim BG, Lee JH, Bae DS, Park CS.
    View PubMed
  • Hum Pathol. 2005 Jun;36(6):626-33. Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia Lee JW11, Yong Song S, Choi JJ, Lee SJ, Kim BG, Park CS, Lee JH, Lin CY, Dickson RB, Bae DS.
    View PubMed
  • Gynecol Oncol. 2005 Apr;97(1):53-9. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia Lee JW11, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS.
    View PubMed